FDA approves IASO Bio’s IND for equecabtagene autoleucel
IASO Biotherapeutics has secured US Food and Drug Administration (FDA) approval for its investigational new drug (IND) application for equecabtagene…
All articles by Soumya Sharma
Soumya Sharma
-
-
Blue Earth and Seibersdorf expand radiopharmaceutical manufacture deal
Blue Earth Therapeutics has broadened its manufacturing collaboration with Seibersdorf Labor to include the production of its investigational 225Ac-based radioligand…
-
AusperBio AHB-137 gains breakthrough status in China for CHB
AusperBio Therapeutics and Ausper Biopharma have gained breakthrough therapy designation (BTD) in China for their investigational drug, AHB-137, to treat…
-
ODAIA wins $25m funding to boost commercial insights platform for pharma
ODAIA, a life sciences predictive analytics and commercial insights provider, has secured an investment of $25m in its Series B…
-
Verismo Therapeutics’ SynKIR-110 receives fast track designation from FDA
Verismo Therapeutics has received fast track designation from the US Food and Drug Administration (FDA) for its investigational new drug,…
